Tony Murphy was a solid 20-a-day smoker. His attempts at quitting lasted at best days, often only hours, as his craving for a ...

Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

BRP, identified through peptide prediction, may revolutionize weight loss treatment, offering efficacy without the ...

BRP emerges as a promising peptide for weight loss, activating appetite control pathways without triggering nausea, paving ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

At the pace with which the proportion of overweight people is growing, half of Nepal’s adult population will be obese by 2050 ...

BRINP2-related peptide, or BRP, is a naturally occurring molecule that can suppress appetite and promote weight loss in mice ...

Scientists at Stanford Medicine have discovered a naturally occurring molecule, BRP, which aids in weight loss while avoiding the side effects associated with drugs like Ozempic. This molecule targets ...

Stanford Medicine scientists have tested a naturally occurring molecule; the best part of the study is it cancels the side effects. It has been nicknamed BRP and offers a 'more targeted approach to ...

Scientists have discovered a naturally occurring molecule that aids appetite control and weight loss so well, it may compete ...